Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain
Lists
Only you see this
Abstract
Hematopoietic stem cell transplantation (HSCT) is a therapy used for multiple malignant and nonmalignant diseases, with chemotherapy used for pretransplantation myeloablation. The post-HSCT brain contains peripheral engrafted parenchymal macrophages, despite their absence in the normal brain, with the engraftment mechanism still undefined. Here we show that HSCT chemotherapy broadly disrupts mouse brain regenerative populations, including a permanent loss of adult neurogenesis. Microglial density was halved, causing microglial process expansion, coinciding with indicators of broad senescence. Although microglia expressed cell proliferation markers, they underwent cell cycle arrest in S phase with a majority expressing the senescence and antiapoptotic marker p21. In vivo single-cell tracking of microglia after recovery from chemical depletion showed loss of their regenerative capacity, subsequently replaced with donor macrophages. We propose that HSCT chemotherapy causes microglial senescence with a gradual decrease to a critical microglial density, providing a permissive niche for peripheral macrophage engraftment of the brain.
BibTeX
@inproceedings{sailor2022hematopoietic,
author = {Kurt A. Sailor and Georgios Agoranos and Sergio López-Manzaneda and Satoru Tada and Béatrix Gillet-Legrand and Corentin Guérinot and Jean‐Baptiste Masson and Christian L. Vestergaard and Melissa Bonner and Khatuna Gagnidze and Gábor Veres and Pierre‐Marie Lledo and Nathalie Cartier},
title = {{Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain}},
booktitle = {Nature Medicine},
year = {2022},
doi = {10.1038/s41591-022-01691-9},
}Loading related content...